Transparency notification
September 19 2019 - 4:01PM
Transparency notification
Mechelen, Belgium; 19 september 2019; 22.01 CET;
regulated information – Galapagos NV (Euronext & NASDAQ: GLPG)
received a transparency notification from Sands Capital Management,
LLC.
Pursuant to Belgian transparency legislation1, Galapagos
received a transparency notification on 16 September 2019 from
Sands Capital Management, LLC, who notified that it holds 2,803,887
of Galapagos’ voting rights in American Depository Receipts. This
represents 4.55% of Galapagos’ currently outstanding 61,652,086
shares. Sands Capital Management, LLC, thus crossed passively below
the 5% threshold of Galapagos’ voting rights, due to the share
issuance by Galapagos on 23 August 2019. The full transparency
notice is available on the Galapagos website.
About Galapagos
Galapagos (Euronext & NASDAQ: GLPG)
discovers and develops small molecule medicines with novel modes of
action, three of which show promising patient results and are
currently in late-stage development in multiple diseases. The
company’s pipeline comprises Phase 3 through to discovery programs
in inflammation, fibrosis, osteoarthritis and other indications.
Galapagos’ ambition is to become a leading global biopharmaceutical
company focused on the discovery, development and commercialization
of innovative medicines. More information at www.glpg.com.
Galapagos
Contacts |
|
Investors: |
Media: |
Elizabeth
Goodwin |
Carmen
Vroonen |
VP IR |
Senior Director
Communications |
+1 781 460
1784 |
+32 473 824
874 |
|
|
Sofie Van Gijsel
|
Evelyn Fox |
Director
IR |
Director
Communications |
+32 485 19 14
15 |
+31 6 53 591
999 |
ir@glpg.com |
communications@glpg.com |
1 Belgian Act of 2 May 2007 on the disclosure
of major shareholdings in issuers whose shares are admitted to
trading on a regulated market.
- Sands Capital TN Sep 2019_EN
Galapagos (EU:GLPG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Galapagos (EU:GLPG)
Historical Stock Chart
From Jul 2023 to Jul 2024